PHIO PHARMACEUTICALS CORP. Lessee, Operating Lease, Liability, to be Paid, Year One
PHIO PHARMACEUTICALS CORP. (PHIO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $35.00 thousand as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2024-04-01
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $35.00K.
- 2023-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $35.00K.
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $35.00K.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $35.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2023-12-31 | $35.00K 10-K · filed 2024-04-01 |
| 2023-09-30 | $35.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $35.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $35.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $140.00K 10-K · filed 2023-03-22 |
| 2022-09-30 | $140.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $140.00K 10-Q · filed 2022-08-11 |
| 2021-12-31 | $135.00K 10-K · filed 2022-03-22 |
| 2021-09-30 | $135.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $135.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $135.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $132.00K 10-K · filed 2021-03-25 |
| 2019-12-31 | $128.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |